Dis­cus­sion on Phar­mac’s fund­ing cri­te­ria

Auckland City Harbour News - - NEWS -

New Zealan­ders are be­ing asked to share their views on how Phar­mac, the gov­ern­ment’s medicine fund­ing agency, makes its de­ci­sions sur­round­ing drug fund­ing.

A pub­lic fo­rum will be held in Mt Al­bert next week as part of a na­tion­wide re­view of the agency’s de­ci­sion-mak­ing cri­te­ria.

Crit­i­cal to the de­bate will be whether cer­tain pa­tients with life-threat­en­ing health is­sues are granted ac­cess to ex­pen­sive but po­ten­tially life-restor­ing med­i­ca­tions.

Chief ex­ec­u­tive St­ef­fan Crausaz says Phar­mac has used the cri­te­ria for nearly 20 years and it is es­sen­tial the ser­vices the agency pro­vides re­flect the pref­er­ences of the com­mu­nity to the best ex­tent pos­si­ble.

‘‘Phar­mac’s work has changed and ex­panded since the de­ci­sion cri­te­ria were first put in place.

‘‘There may be some ad­di­tional things that peo­ple think are im­por­tant for us to take into ac­count when we are mak­ing de­ci­sions about phar­ma­ceu­ti­cal fund­ing.’’

One group urg­ing Ki­wis to have a say is the Parox­ys­mal Noc­tur­nal Hae­moglobin­uria sup­port as­so­ci­a­tion which is seek­ing fund­ing for the life­sav­ing drug Soliris. The drug treats the rare and fa­tal blood dis­or­der.

The fo­rum is at the Mt Al­bert War Me­mo­rial Hall on June 25 from 10.45am to 1pm.

Sub­mis­sions re­gard­ing Soliris are open for pub­lic re­sponse un­til July 31.

See phar­mac.health.nz.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.